3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
32
Neoplasm Metastasis
5
Advanced Breast Cancer
4
Triple Negative Breast Neoplasms
3
Polycystic Ovary Syndrome
3
Neoplasms
3
Endometrial Neoplasms
3
Recurrence
2
Prostatic Neoplasms
2
Ovarian Neoplasms
2
Infertility
2
Carcinoma, Intraductal, Noninfiltrating
2
Breast Neoplasms, Male
2
Uterine Cervical Neoplasms
1
Unilateral Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Sexual Dysfunctions, Psychological
1
Pathologic Complete Response
1
Neoplasms by Site
1
Leiomyoma
1
Hereditary Sensory and Autonomic Neuropathies
1
Hemangiosarcoma
1
Head and Neck Neoplasms
1
HR+/HER2- Breast Cancer
1
HER2 Negative Breast Cancer
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Ductal
1
Breast Neoplasm Female
1
Breast Diseases
1
Interventions
pertuzumab
2
Trastuzumab
2
Taxes
2
Standard of Care
2
Practice Guidelines as Topic
2
Paclitaxel
2
High-Energy Shock Waves
2
Docetaxel
2
trastuzumab biosimilar HLX02
1
Transcutaneous Electric Nerve Stimulation
1
Specimen Handling
1
Radiation Dose Hypofractionation
1
PF-05280014
1
Ontruzant
1
Ogivri
1
Minoxidil
1
Methods
1
Magnetic Resonance Spectroscopy
1
Immunoglobulin G
1
Educational Status
1
Early Intervention, Educational
1
Disulfides
1
Carboplatin
1
Biopsy
1
2C4 antibody
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Anatomic Stage I Breast Cancer AJCC v8
×
Letrozole
×
30 days
×
Clear all
No trials found.